The comparison is instructive
Additionally, case reports and prospective cohort studies of patients treated with GLP-1 RAs have demonstrated reductions in the Psoriasis Area and Severity Index (PASI) score, Physicians Global Assessment (PGA), and Dermatology Life Quality Index (DLQI) after 212 months of treatment [11,12,13,14,15,16]
As of mid-2025, all compounding grace periods have expired for both semaglutide and tirzepatide
Successful long-term outcomes with semaglutide therapy often depend on establishing sustainable eating patterns that align with the medication's effects
Peak weight loss acceleration occurs during the dose-titration phase (weeks 4-20), with clinical trial data showing an average loss of 15-22% of baseline body weight by week 20
N., Verma, S., Borlaug, B